132 related articles for article (PubMed ID: 37057379)
1. Acral BRAF-mutated tubular adenoma should be distinguished from HPV42-related digital papillary adenocarcinoma.
Kervarrec T; Busam KJ
J Cutan Pathol; 2023 Jun; 50(6):577-579. PubMed ID: 37057379
[No Abstract] [Full Text] [Related]
2. Association of HPV42 with digital papillary adenocarcinoma and the use of in situ hybridization for its distinction from acral hidradenoma and diagnosis at non-acral sites.
Vanderbilt C; Brenn T; Moy AP; Harloe G; Ariyan C; Athanasian E; Busam KJ
Mod Pathol; 2022 Oct; 35(10):1405-1410. PubMed ID: 35538210
[TBL] [Abstract][Full Text] [Related]
3. [Cystic tubulopapillary adenoma with apocrine differentiation and BRAF V600E mutation. A case report and review of the literature].
Moreno Ontalba A; Gómez Durán Á; Ruiz Cabezas L; Cidoncha Pérez E; Díaz Delgado M; Rubio Fernández A
Rev Esp Patol; 2022 Sep; 55 Suppl 1():S64-S68. PubMed ID: 36075666
[TBL] [Abstract][Full Text] [Related]
4. Digital papillary adenoma (ADPA) and aggressive digital papillary adenocarcinoma (AdPACa).
Gorva AD
Am J Dermatopathol; 2005 Dec; 27(6):546-7; author reply 547. PubMed ID: 16314709
[No Abstract] [Full Text] [Related]
5. Aggressive digital papillary adenoma.
Viroslav S; Finan MC; Smith JW
Orthopedics; 1996 Oct; 19(10):899-900. PubMed ID: 8905867
[No Abstract] [Full Text] [Related]
6. BRAF and KRAS mutations in tubular apocrine adenoma and papillary eccrine adenoma of the skin.
Liau JY; Tsai JH; Huang WC; Lan J; Hong JB; Yuan CT
Hum Pathol; 2018 Mar; 73():59-65. PubMed ID: 29241739
[TBL] [Abstract][Full Text] [Related]
7. A Case Report of Papillary Digital Adenocarcinoma With BRAFV600E Mutation and Quantified Mutational Burden.
Trager MH; Jurkiewicz M; Khan S; Niedt GW; Geskin LJ; Carvajal RD
Am J Dermatopathol; 2021 Jan; 43(1):57-59. PubMed ID: 32568833
[TBL] [Abstract][Full Text] [Related]
8. Aggressive digital papillary adenocarcinoma (aggressive digital papillary adenoma and adenocarcinoma revisited).
Duke WH; Sherrod TT; Lupton GP
Am J Surg Pathol; 2000 Jun; 24(6):775-84. PubMed ID: 10843279
[TBL] [Abstract][Full Text] [Related]
9. Aggressive digital papillary adenocarcinoma: a case report and review of the literature.
Jih DM; Elenitsas R; Vittorio CC; Berkowitz AR; Seykora JT
Am J Dermatopathol; 2001 Apr; 23(2):154-7. PubMed ID: 11285414
[TBL] [Abstract][Full Text] [Related]
10. Sweat Gland Tumors Arising on Acral Sites: A Molecular Survey.
Kervarrec T; Tallet A; Macagno N; de la Fouchardière A; Pissaloux D; Tirode F; Bravo IG; Nicolas A; Baulande S; Sohier P; Balme B; Osio A; Jullie ML; Moulonguet I; Bonsang B; Tournier E; Herfs M; Frouin E; Zidan A; Calonje E; Berthon P; Touzé A; Seris A; Mortier L; Jouary T; Cribier B; Battistella M
Am J Surg Pathol; 2023 Oct; 47(10):1096-1107. PubMed ID: 37505808
[TBL] [Abstract][Full Text] [Related]
11. Metastatic aggressive digital papillary adenocarcinoma.
Altman CE; Hamill RL; Elston DM
Cutis; 2003 Aug; 72(2):145-7. PubMed ID: 12953940
[TBL] [Abstract][Full Text] [Related]
12. Aggressive digital papillary adenocarcinoma.
Ceballos PI; Penneys NS; Acosta R
J Am Acad Dermatol; 1990 Aug; 23(2 Pt 2):331-4. PubMed ID: 2394851
[TBL] [Abstract][Full Text] [Related]
13. [Digital papillary adenocarcinoma : Four case reports with brief literature review].
Held L; Mentzel T; Paredes BE; Griewank KG; Itzlinger-Monshi B; Rütten A
Hautarzt; 2019 Mar; 70(3):204-209. PubMed ID: 30478600
[TBL] [Abstract][Full Text] [Related]
14. Aggressive digital papillary adenoma and adenocarcinoma. A clinicopathological study of 57 patients, with histochemical, immunopathological, and ultrastructural observations.
Kao GF; Helwig EB; Graham JH
J Cutan Pathol; 1987 Jun; 14(3):129-46. PubMed ID: 3301927
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathologic Characterization of Hidradenoma on Acral Sites: A Diagnostic Pitfall With Digital Papillary Adenocarcinoma.
Wiedemeyer K; Gill P; Schneider M; Kind P; Brenn T
Am J Surg Pathol; 2020 May; 44(5):711-717. PubMed ID: 31876586
[TBL] [Abstract][Full Text] [Related]
16. BRAF mutation in papillary thyroid microcarcinoma: the promise of better risk management.
Xing M
Ann Surg Oncol; 2009 Apr; 16(4):801-3. PubMed ID: 19159982
[No Abstract] [Full Text] [Related]
17. Immunohistochemical detection of the BRAF V600E-mutated protein in papillary thyroid carcinoma.
Koperek O; Kornauth C; Capper D; Berghoff AS; Asari R; Niederle B; von Deimling A; Birner P; Preusser M
Am J Surg Pathol; 2012 Jun; 36(6):844-50. PubMed ID: 22592144
[TBL] [Abstract][Full Text] [Related]
18. BRAF V600E mutation in papillary thyroid carcinoma: significant association with node metastases and extra thyroidal invasion.
Chakraborty A; Narkar A; Mukhopadhyaya R; Kane S; D'Cruz A; Rajan MG
Endocr Pathol; 2012 Jun; 23(2):83-93. PubMed ID: 22105775
[TBL] [Abstract][Full Text] [Related]
19. An aggressive treatment for aggressive digital papillary adenocarcinoma.
Inaloz HS; Patel GK; Knight AG
Cutis; 2002 Mar; 69(3):179-82; quiz 210. PubMed ID: 11926336
[TBL] [Abstract][Full Text] [Related]
20. BRAF(V600E) mutation influences hypoxia-inducible factor-1alpha expression levels in papillary thyroid cancer.
Zerilli M; Zito G; Martorana A; Pitrone M; Cabibi D; Cappello F; Giordano C; Rodolico V
Mod Pathol; 2010 Aug; 23(8):1052-60. PubMed ID: 20473281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
